Literature DB >> 26095322

Evaluation of a newly developed measure of theory of mind: The virtual assessment of mentalising ability.

Allana L Canty1, David L Neumann1, Jennifer Fleming2,3, David H K Shum1.   

Abstract

This study examined the reliability and validity of the Virtual Assessment of Mentalising Ability (VAMA). The VAMA consists of 12 video clips depicting a social drama imposed within an interactive virtual environment with questions assessing the mental states of virtual friends. Response options capture the continuum of ability (i.e., impaired, reduced, accurate, and hypermentalising) within first- and second-order cognitive and affective theory of mind (ToM). Sixty-two healthy participants were administered the VAMA, three other ToM measures, and additional measures of neurocognitive abilities and social functioning. The VAMA had sound internal consistency and high test-retest reliability. Significant correlations between performance on the VAMA and other ToM measures provided preliminary evidence of convergent validity. Small to moderate correlations were observed between performance on the VAMA and neurocognitive tasks. Further, the VAMA was found to correlate significantly with indices of social functioning and was rated as more immersive, more reflective of everyday ToM processes, and was afforded a higher recommendation than an existing computer-based ToM task. These results provide potential evidence that the VAMA is an ecologically valid tool that is sensitive to the spread of ability that can occur in ToM subprocesses and may be a valuable addition to existing ToM measures. Future research should explore the validity and utility of the VAMA in larger, more diverse samples of healthy adult and clinical populations.

Entities:  

Keywords:  Assessment; Ecological validity; Social cognition; Theory of mind; Virtual reality

Mesh:

Year:  2015        PMID: 26095322     DOI: 10.1080/09602011.2015.1052820

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  7 in total

1.  Metaperception in Adolescents With and Without Autism Spectrum Disorder.

Authors:  Lauren V Usher; Catherine A Burrows; Daniel S Messinger; Heather A Henderson
Journal:  J Autism Dev Disord       Date:  2018-02

Review 2.  A Systematic Review of the Current Measures of Theory of Mind in Adults with Schizophrenia.

Authors:  Ya-Chin Yeh; Chung-Ying Lin; Ping-Chia Li; Chi-Fa Hung; Chun-Hua Cheng; Ming-Hui Kuo; Kuan-Lin Chen
Journal:  Int J Environ Res Public Health       Date:  2021-07-04       Impact factor: 3.390

3.  Theory of Mind as a Correlate of Bystanders' Reasoning About Intergroup Bullying of Syrian Refugee Youth.

Authors:  Seçil Gönültaş; Kelly Lynn Mulvey
Journal:  Front Psychol       Date:  2022-03-30

4.  Thinking about what he thinks of what I think: Assessing higher theory of mind abilities in Indian bilingual children between 3.0 and 8.11 years of age.

Authors:  Zeba Hussain Raisa; Sudhin Karuppali; Jayashree Sunil Bhat; Gagan Bajaj
Journal:  Indian J Psychiatry       Date:  2019 Mar-Apr       Impact factor: 1.759

5.  The emotion storyboard: A method to examine social judgments of emotion.

Authors:  Kaitlin McCormick-Huhn; Stephanie A Shields
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

6.  Using virtual reality to assess theory of mind subprocesses and error types in early and chronic schizophrenia.

Authors:  Allana L Canty; David L Neumann; David H K Shum
Journal:  Schizophr Res Cogn       Date:  2017-09-26

7.  Theory of mind, emotion recognition, delusions and the quality of the therapeutic relationship in patients with psychosis - a secondary analysis of a randomized-controlled therapy trial.

Authors:  Stephanie Mehl; Klaus Hesse; Anna-Christine Schmidt; Martin W Landsberg; Daniel Soll; Andreas Bechdolf; Jutta Herrlich; Tilo Kircher; Stefan Klingberg; Bernhard W Müller; Georg Wiedemann; Andreas Wittorf; Wolfgang Wölwer; Michael Wagner
Journal:  BMC Psychiatry       Date:  2020-02-10       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.